Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Aoxin Q & M Dental Group's annualized net income for the quarter that ended in Dec. 2025 was S$1.55 Mil. Aoxin Q & M Dental Group's average shareholder tangible equity for the quarter that ended in Dec. 2025 was S$32.58 Mil. Therefore, Aoxin Q & M Dental Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 4.76%.
The historical rank and industry rank for Aoxin Q & M Dental Group's Return-on-Tangible-Equity or its related term are showing as below:
SGX:1D4'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -30.79 Med: -5.9 Max: 10.07
Current: 4.24
During the past 13 years, Aoxin Q & M Dental Group's highest Return-on-Tangible-Equity was 10.07%. The lowest was -30.79%. And the median was -5.90%.
SGX:1D4's Return-on-Tangible-Equity is ranked worse than 65.92% of 578
companies
in the Healthcare Providers & Services industry
Industry Median: 10.635
vs SGX:1D4: 4.24
Aoxin Q & M Dental Group (SGX:1D4) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Aoxin Q & M Dental Group Return-on-Tangible-Equity Related Terms
Aoxin Q & M Dental Group Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Aoxin Q & M Dental Group's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aoxin Q & M Dental Group Return-on-Tangible-Equity Chart
SGX:1D4 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Aoxin Q & M Dental Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aoxin Q & M Dental Group Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aoxin Q & M Dental Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Aoxin Q & M Dental Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 4.76% mean?
Aoxin Q & M Dental Group (SGX:1D4) has a Return-on-Tangible-Equity of 4.76% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aoxin Q & M Dental Group and its competitors. According to the industry distribution chart, Aoxin Q & M Dental Group ranks #381 out of 578 companies in the Healthcare Providers & Services industry, placing it in the top 65.9%.
Is Aoxin Q & M Dental Group's Return-on-Tangible-Equity too high?
Aoxin Q & M Dental Group's current Return-on-Tangible-Equity is 4.76%. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.64. Aoxin Q & M Dental Group's value of 4.76% is 55.2% below this industry median. Based on the distribution chart, Aoxin Q & M Dental Group ranks #381 out of 578 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Aoxin Q & M Dental Group has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aoxin Q & M Dental Group's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aoxin Q & M Dental Group ranks #381 out of 578 companies for Return-on-Tangible-Equity. This places Aoxin Q & M Dental Group in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.64. Aoxin Q & M Dental Group's value of 4.76% is 55.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.64, based on 578 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aoxin Q & M Dental Group's current Return-on-Tangible-Equity of 4.76% is 55.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aoxin Q & M Dental Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aoxin Q & M Dental Group's current Return-on-Tangible-Equity is 4.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aoxin Q & M Dental Group stock overvalued right now?
Based on GuruFocus' analysis, Aoxin Q & M Dental Group (SGX:1D4) is currently considered Significantly Overvalued. The stock's GF Value™ is S$0.05, compared to a current price of S$0.24 — trading 370% above its estimated fair value. The current Return-on-Tangible-Equity is 4.76% and 55.2% below the Healthcare Providers & Services industry median of 10.64. Aoxin Q & M Dental Group's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Aoxin Q & M Dental Group (SGX:1D4), the current Return-on-Tangible-Equity is 4.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aoxin Q & M Dental Group (SGX:1D4) Overvalued in 2026?
Based on GuruFocus' analysis, Aoxin Q & M Dental Group stock appears to be overvalued.
The current stock price of S$0.24 is trading 370% above its estimated GF Value™ of S$0.05.
GuruFocus considers Aoxin Q & M Dental Group to be Significantly Overvalued.
Key valuation signals for SGX:1D4:
Return-on-Tangible-Equity: 4.76%
GF Value™: S$0.05 vs. price of S$0.24 (370% above fair value)
Industry Position: 55.2% below the Healthcare Providers & Services median (#381 of 578)
No single metric tells the full story. See the SGX:1D4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aoxin Q & M Dental Group Ltd, along with its subsidiaries, offers private dental services, dental equipment, and supplies. The various dental care services offered by the Group include Stomatology and general dentistry, Endodontics, Orthodontics, Periodontics, Dental implantology, and many more. Its dental equipment and supplies portfolio includes dental chairs, ultrasound scanners, dental instruments, materials, and consumables for dental hospitals, clinics, distributors, and laboratories. The Group's reportable operating segments are: Primary healthcare, which generates the maximum revenue, Distribution of dental equipment and supplies, and Laboratory services. Geographically, it generates maximum revenue from the People's Republic of China (PRC) and the rest from Singapore.
44GF Score
Get the complete analysis for SGX:1D4
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1D4 has been successfully added to your 
